0
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: not found

      Predicting Real-World Effectiveness of Cancer Therapies Using Overall Survival and Progression-Free Survival from Clinical Trials: Empirical Evidence for the ASCO Value Framework.

      Read this article at

      ScienceOpenPublisherPubMed
      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          To measure the relationship between randomized controlled trial (RCT) efficacy and real-world effectiveness for oncology treatments as well as how this relationship varies depending on an RCT's use of surrogate versus overall survival (OS) endpoints.

          Related collections

          Author and article information

          Journal
          Value Health
          Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research
          Elsevier BV
          1524-4733
          1098-3015
          July 18 2017
          : 20
          : 7
          Affiliations
          [1 ] Leonard D. Schaeffer Center for Health Policy and Economics, University of Southern California, Los Angeles, CA, USA. Electronic address: dlakdawa@usc.edu.
          [2 ] Precision Health Economics, Los Angeles, CA, USA.
          [3 ] Novartis Pharmaceuticals, East Hanover, NJ, USA.
          [4 ] University of California, Los Angeles, CA, USA.
          [5 ] Cedars-Sinai Medical Center, Los Angeles, CA, USA.
          Article
          S1098-3015(17)30203-6
          10.1016/j.jval.2017.04.003
          28712615
          b5fa2b07-a896-48b7-ac12-2f2cfc6cdb08
          History

          treatment comparisons,mortality,methodology,cancer
          treatment comparisons, mortality, methodology, cancer

          Comments

          Comment on this article